Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholine.

Por Van Der Luit, Arnold H, Budde, Marianne, Verheij, Marcel, Van Blitterswijk, Wim J
Publicado em 2003

Radiation-Induced Microvascular Injury as a Mechanism of Salivary Gland Hypofunction and Potential Target for Radioprotectors

Por Mizrachi, Aviram, Cotrim, Ana P., Katabi, Nora, Mitchell, James B., Verheij, Marcel, Haimovitz-Friedman, Adriana
Publicado no Radiat Res (2016)

Ceramide: second messenger or modulator of membrane structure and dynamics?

Por van Blitterswijk, Wim J, van der Luit, Arnold H, Veldman, Robert Jan, Verheij, Marcel, Borst, Jannie
Publicado em 2003

Treatment of resectable gastric cancer

Por Dikken, Johan L., van de Velde, Cornelis J.H., Coit, Daniel G., Shah, Manish A., Verheij, Marcel, Cats, Annemieke
Publicado em 2012

The New American Joint Committee on Cancer/International Union Against Cancer Staging System for Adenocarcinoma of the Stomach: Increased Complexity without Clear Improvement in Pr...

Por Dikken, Johan L., van de Velde, Cornelis J. H., Gönen, Mithat, Verheij, Marcel, Brennan, Murray F., Coit, Daniel G.
Publicado em 2012

Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective

Por Lambrecht, Marie, Melidis, Christos, Sonke, Jan-Jakob, Adebahr, Sonja, Boellaard, Ronald, Verheij, Marcel, Guckenberger, Matthias, Nestle, Ursula, Hurkmans, Coen
Publicado no Radiat Oncol (2016)

Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid r...

Por Van der Luit, Arnold H., Budde, Marianne, Zerp, Shuraila, Caan, Wendy, Klarenbeek, Jeffrey B., Verheij, Marcel, van Blitterswijk, Wim J.
Publicado em 2006

Extended lymph node dissection for gastric cancer from a European perspective

Por Dikken, Johan L., Verheij, Marcel, Cats, Annemieke, Jansen, Edwin P. M., Hartgrink, Henk H., van de Velde, Cornelis J. H.
Publicado em 2011

Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma

Por Kroon, Paula, Gadiot, Jules, Peeters, Marlies, Gasparini, Alessia, Deken, Marcel A., Yagita, Hideo, Verheij, Marcel, Borst, Jannie, Blank, Christian U., Verbrugge, Inge
Publicado no Cancer Immunol Immunother (2016)

AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis

Por Zerp, Shuraila F, Stoter, Rianne, Kuipers, Gitta, Yang, Dajun, Lippman, Marc E, van Blitterswijk, Wim J, Bartelink, Harry, Rooswinkel, Rogier, Lafleur, Vincent, Verheij, Marcel
Publicado em 2009

Short-chain sphingolipids for enhanced cellular uptake of liposome-encapsulated amphiphilic anti-cancer drugs

Por Pedrosa, Lília RC, van Hell, Albert, van Blitterswijk, Wim, Seynhaeve, Ann LB, Eggermont, Alexander MM, ten Hagen, Timo LM, Verheij, Marcel, Koning, Gerben A
Publicado em 2010

R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology

Por Verkooijen, Helena M., Kerkmeijer, Linda G. W., Fuller, Clifton D., Huddart, Robbert, Faivre-Finn, Corinne, Verheij, Marcel, Mook, Stella, Sahgal, Arjun, Hall, Emma, Schultz, Chris
Publicado no Front Oncol (2017)

NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

Por van den Heuvel, Michel M, Verheij, Marcel, Boshuizen, Rogier, Belderbos, José, Dingemans, Anne-Marie C, De Ruysscher, Dirk, Laurent, Julien, Tighe, Robert, Haanen, John, Quaratino, Sonia
Publicado no J Transl Med (2015)

Conditional Probability of Survival Nomogram for 1-, 2-, and 3-Year Survivors After an R0 Resection for Gastric Cancer

Por Dikken, Johan L., Baser, Raymond E., Gonen, Mithat, Kattan, Michael W., Shah, Manish A., Verheij, Marcel, van de Velde, Cornelis J. H., Brennan, Murray F., Coit, Daniel G.
Publicado em 2012

Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer

Por Zerp, Shuraila F., Stoter, T. Rianne, Hoebers, Frank J. P., van den Brekel, Michiel W. M., Dubbelman, Ria, Kuipers, Gitta K., Lafleur, M. Vincent M., Slotman, Ben J., Verheij, Marcel
Publicado no Radiat Oncol (2015)

(99m)Tc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy

Por Hoebers, Frank J. P., Kartachova, Marina, de Bois, Josien, van den Brekel, Michiel W. M., van Tinteren, Harm, van Herk, Marcel, Rasch, Coen R. N., Valdés Olmos, Renato A., Verheij, Marcel
Publicado em 2007

Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck...

Por Heukelom, Jolien, Hamming, Olga, Bartelink, Harry, Hoebers, Frank, Giralt, Jordi, Herlestam, Teresa, Verheij, Marcel, Brekel, Michiel van den, Vogel, Wouter, Slevin, Nick, Deutsch, Eric, Sonke, Jan-Jakob, Lambin, Philippe, Rasch, Coen
Publicado em 2013

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)

Por van Grieken Nicole CT, Boot Henk, Jansen Edwin PM, Putter Hein, Lind Pehr A, Maurits Swellengrebel HA, van Sandick Johanna W, Dikken Johan L, van de Velde Cornelis JH, Verheij Marcel, Cats Annemieke
Publicado em 2011-08-01

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)

Por Dikken, Johan L, van Sandick, Johanna W, Maurits Swellengrebel, HA, Lind, Pehr A, Putter, Hein, Jansen, Edwin PM, Boot, Henk, van Grieken, Nicole CT, van de Velde, Cornelis JH, Verheij, Marcel, Cats, Annemieke
Publicado em 2011

Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistance

Por van Hell, Albert J., Melo, Manuel N., van Blitterswijk, Wim J., Gueth, Dayana M., Braumuller, Tanya M., Pedrosa, Lilia R. C., Song, Ji-Ying, Marrink, Siewert J., Koning, Gerben A., Jonkers, Jos, Verheij, Marcel
Publicado em 2013